Jeffrey Eisele - 22 Jan 2024 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
/s/ David Watson, attorney-in-fact for Jeffrey Eisele
Issuer symbol
APLS
Transactions as of
22 Jan 2024
Transactions value $
-$104,449
Form type
4
Filing time
23 Jan 2024, 18:05:11 UTC
Previous filing
18 Jan 2024
Next filing
24 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale -$104,448 -1,607 -2.38% $65 65,836 22 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on the Restricted Stock Units released on 01/19/2024.